Share on StockTwits

Celsion (NASDAQ:CLSN) Director Frederick J. Fritz purchased 4,000 shares of Celsion stock on the open market in a transaction that occurred on Thursday, August 14th. The stock was purchased at an average cost of $3.20 per share, for a total transaction of $12,800.00. Following the completion of the acquisition, the director now directly owns 30,311 shares of the company’s stock, valued at approximately $96,995. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.

Celsion (NASDAQ:CLSN) opened at 3.12 on Friday. Celsion has a one year low of $2.82 and a one year high of $6.6216. The stock’s 50-day moving average is $3.24 and its 200-day moving average is $3.39. The company’s market cap is $53.7 million.

Celsion (NASDAQ:CLSN) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($0.38) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.32) by $0.06. Analysts expect that Celsion will post $-1.33 EPS for the current fiscal year.

Separately, analysts at Paradigm Capital raised their price target on shares of Celsion from $12.50 to $13.50 in a research note on Thursday, July 17th. They now have a “buy” rating on the stock.

Celsion Corporation (NASDAQ:CLSN) is an oncology drug development company focused on improving treatment for those suffering with aggressive and difficult to treat forms of cancer.

Receive News & Ratings for Celsion Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsion Co and related companies with Analyst Ratings Network's FREE daily email newsletter.